117 related articles for article (PubMed ID: 2579476)
41. Nafenopin-induced peroxisome proliferation in vitamin A deficient rats.
Lawrence JW; Foxworthy PS; Perry DN; Jensen CB; Giera DD; Meador VP; Eacho PI
Biochem Pharmacol; 1995 Mar; 49(7):915-9. PubMed ID: 7741763
[TBL] [Abstract][Full Text] [Related]
42. Wy-14,643, a peroxisome proliferator, inhibits compensative cell proliferation and hepatocyte growth factor mRNA expression in the rat liver.
Motoki Y; Tamura H; Watanabe T; Suga T
Cancer Lett; 1999 Jan; 135(2):145-50. PubMed ID: 10096422
[TBL] [Abstract][Full Text] [Related]
43. Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643.
Conway JG; Tomaszewski KE; Olson MJ; Cattley RC; Marsman DS; Popp JA
Carcinogenesis; 1989 Mar; 10(3):513-9. PubMed ID: 2924396
[TBL] [Abstract][Full Text] [Related]
44. Alterations of pyrimidine and nucleic acid synthesis during adaptive growth of liver induced by nafenopin, a peroxisome proliferator. An in vivo study.
Seifert J; Mostecká H
Carcinogenesis; 1989 Aug; 10(8):1383-8. PubMed ID: 2473851
[TBL] [Abstract][Full Text] [Related]
45. Nafenopin-induced rat liver peroxisome proliferation reduces DNA methylation by N-nitrosodimethylamine in vivo.
Wiestler OD; Schmerold I; Fringes B; Volk B; Kleihues P
Carcinogenesis; 1985 Sep; 6(9):1309-13. PubMed ID: 4028330
[TBL] [Abstract][Full Text] [Related]
46. Hepatic peroxisome proliferation: induction by BR-931, a hypolipidemic analog of WY-14,643.
Reddy JK; Azarnoff DL; Sirtori CR
Arch Int Pharmacodyn Ther; 1978 Jul; 234(1):4-14. PubMed ID: 708142
[TBL] [Abstract][Full Text] [Related]
47. Role of hepatic non-parenchymal cells in the response of rat hepatocytes to the peroxisome proliferator nafenopin in vitro.
Hasmall SC; West DA; Olsen K; Roberts RA
Carcinogenesis; 2000 Dec; 21(12):2159-65. PubMed ID: 11133804
[TBL] [Abstract][Full Text] [Related]
48. Effects of the hepatocarcinogenic peroxisome-proliferating hypolipidemic agents clofibrate and nafenopin on the rat liver cell membrane enzymes gamma-glutamyltranspeptidase and alkaline phosphatase and on the early stages of liver carcinogenesis.
Numoto S; Furukawa K; Furuya K; Williams GM
Carcinogenesis; 1984 Dec; 5(12):1603-11. PubMed ID: 6149819
[TBL] [Abstract][Full Text] [Related]
49. Comparison of the effects of nafenopin on hepatic peroxisome proliferation and replicative DNA synthesis in the rat and Syrian hamster.
Price RJ; Evans JG; Lake BG
Food Chem Toxicol; 1992 Nov; 30(11):937-44. PubMed ID: 1473786
[TBL] [Abstract][Full Text] [Related]
50. Hepatobiliary elimination of the peroxisome proliferator nafenopin by conjugation and subsequent ATP-dependent transport across the canalicular membrane.
Jedlitschky G; Leier I; Böhme M; Buchholz U; Bar-Tana J; Keppler D
Biochem Pharmacol; 1994 Sep; 48(6):1113-20. PubMed ID: 7945404
[TBL] [Abstract][Full Text] [Related]
51. Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643.
Rose ML; Germolec D; Arteel GE; Schoonhoven R; Thurman RG
Chem Res Toxicol; 1997 Oct; 10(10):1198-204. PubMed ID: 9348444
[TBL] [Abstract][Full Text] [Related]
52. Inhibition instead of enhancement of lipid peroxidation by pretreatment with the carcinogenic peroxisome proliferator nafenopin in rat liver exposed to a high single dose of corn oil.
Huber WW; Grasl-Kraupp B; Stekel H; Gschwentner C; Lang H; Schulte-Hermann R
Arch Toxicol; 1997; 71(9):575-81. PubMed ID: 9285040
[TBL] [Abstract][Full Text] [Related]
53. Comparison of 5-bromo-2-deoxyuridine and [3H]thymidine for studies of hepatocellular proliferation in rodents.
Lanier TL; Berger EK; Eacho PI
Carcinogenesis; 1989 Jul; 10(7):1341-3. PubMed ID: 2736724
[TBL] [Abstract][Full Text] [Related]
54. 32P-postlabeling analysis of peroxisome proliferator-DNA adduct formation in rat liver in vivo and hepatocytes in vitro.
Gupta RC; Goel SK; Earley K; Singh B; Reddy JK
Carcinogenesis; 1985 Jun; 6(6):933-6. PubMed ID: 4006083
[TBL] [Abstract][Full Text] [Related]
55. Increased plasma clearance rate of thyroxine despite decreased 5'-monodeiodination: study with a peroxisome proliferator in the rat.
Kaiser CA; Seydoux J; Giacobino JP; Girardier L; Burger AG
Endocrinology; 1988 Mar; 122(3):1087-93. PubMed ID: 3342745
[TBL] [Abstract][Full Text] [Related]
56. Induction of hepatic ornithine decarboxylase by hypolipidemic drugs with hepatic peroxisome proliferative activity.
Izumi K; Reddy JK; Oyasu R
Carcinogenesis; 1981; 2(7):623-7. PubMed ID: 7273341
[TBL] [Abstract][Full Text] [Related]
57. Induction of peroxisomal acyl CoA oxidase activity and lipid peroxidation in primary rat hepatocyte cultures.
Tomaszewski KE; Heindel SW; Jenkins WL; Melnick RL
Toxicology; 1990 Dec; 65(1-2):49-60. PubMed ID: 2274969
[TBL] [Abstract][Full Text] [Related]
58. Elevated 8-hydroxydeoxyguanosine in hepatic DNA of rats following exposure to peroxisome proliferators: relationship to mitochondrial alterations.
Sausen PJ; Lee DC; Rose ML; Cattley RC
Carcinogenesis; 1995 Aug; 16(8):1795-801. PubMed ID: 7634406
[TBL] [Abstract][Full Text] [Related]
59. Differential induction of peroxisomal and microsomal fatty-acid-oxidising enzymes by peroxisome proliferators in rat liver and kidney. Characterisation of a renal cytochrome P-450 and implications for peroxisome proliferation.
Sharma RK; Lake BG; Makowski R; Bradshaw T; Earnshaw D; Dale JW; Gibson GG
Eur J Biochem; 1989 Sep; 184(1):69-78. PubMed ID: 2776771
[TBL] [Abstract][Full Text] [Related]
60. An upstream region of the enoyl-coenzyme A hydratase/3-hydroxyacyl-coenzyme A dehydrogenase gene directs luciferase expression in liver in response to peroxisome proliferators in transgenic mice.
Alvares K; Fan C; Dadras SS; Yeldandi AV; Rachubinski RA; Capone JP; Subramani S; Iannaccone PM; Rao MS; Reddy JK
Cancer Res; 1994 May; 54(9):2303-6. PubMed ID: 8162569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
